造血原生细胞的来源决定了它们产生先天性淋巴细胞的能力
Said Z Omar1, Vera van Hoeven1, Nienke J E Haverkate1
1Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.
Cytotherapy
|February 16, 2024
概括
在全基造血细胞移植 (HCT) 后,先天性淋巴细胞 (ILCs) 的缓慢恢复可能源于成年造血原生细胞 (HPCs) 区分为ILCs的能力有限. 这影响了移植与宿主疾病 (GVHD) 的风险.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 细胞分化 细胞分化
背景情况:
- 全基性造血细胞移植 (HCT) 对于治疗血液疾病至关重要,但受移植与宿主疾病 (GVHD) 的阻碍.
- 化学疗法和放射治疗等治疗造成的组织损伤加剧了GVHD.
- 先天性淋巴细胞 (ILC) 对于组织修复和平衡至关重要,并且它们在HCT后的存在/重建与减少GVHD和粘膜炎相关.
研究的目的:
- 调查造血原生细胞 (HPC) 分化为成熟的辅助 ILC 子集的能力.
- 从不同的HPC来源探索影响ILC发展的因素.
主要方法:
- 开发一种含有ex vivo树皮细胞的培养系统.
- 从各种来源 (带血液,胎儿肝脏,成人HCT移植,成人骨髓) 培养HPC,以评估ILC差异化.
主要成果:
- 根据HPC来源,ILC的发展有很大的差异.
- 高频率的ILCs是由带血液和胎儿肝脏HPCs产生的.
- 低频率的ILCs,特别是组织保护ILC2和NKp44+ILC3子集,来自成年HPC来源.
结论:
- 成人HPCs在分化为ILCs方面表现出一种内在的限制.
- 这种内在的无能性可能解释了在异构HCT后观察到的慢慢和不完全的ILC恢复.
- 加强ILC复制后HCT的策略可能需要解决成人HPC的差异化潜力.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Cells of the Adaptive Immune Response
986
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
986
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


